South Africa’s TIA Allocates R14 Million ($837,000) Grant to TokaBio for Rapid Livestock Disease Surveillance

PRETORIA — South Africa’s Technology Innovation Agency (TIA) has awarded a R14 million (approximately $837,000) non-dilutive grant to biotechnology startup TokaBio to expand its Molecular Rapid Response and Bio-surveillance Programme.

An entity of the Department of Science, Technology and Innovation, TIA is deploying the capital under its national Bio-Economy Strategy mandate. The grant facilitates faster, geographically targeted detection of high-consequence livestock pathogens, specifically Foot-and-Mouth Disease (FMD) and Avian Influenza, to prevent systemic disruptions across the country's livestock and poultry supply chains.

Safeguarding Export Markets Against Biosecurity Shocks

Recurring livestock disease outbreaks pose a structural vulnerability to South Africa’s agricultural economy. When FMD or Avian Influenza spreads, international trade partners routinely impose immediate sanitary import bans, halting livestock movements and freezing foreign market access for beef, poultry, and ostrich exports.

By establishing early-detection infrastructure, TokaBio’s surveillance platform aims to enable framework mechanisms such as compartmentalization—a biosecurity protocol recognized by international trade bodies that allows disease-free farms and regions to continue exporting even during localized national outbreaks. Maintaining uninterrupted trade flow is critical for a sector that relies heavily on foreign currency revenues from red meat and avian products.

Targeted Mobile Surveillance and Regional Infrastructure

TokaBio's operational rollout centers on decentralized testing infrastructure designed to deliver real-time diagnostic data directly at the farm gate or regional level:

• Limpopo Mobile Lab: Operating out of Modimolle, a mobile laboratory focuses on Avian Influenza monitoring tailored to the region's specialized ostrich and poultry farming sectors.
• KwaZulu-Natal Hub: A dedicated facility supports nationwide monitoring and genetic sequencing for Foot-and-Mouth Disease strains affecting cattle herds.

Combining rapid molecular diagnostic tools with field-deployable units shortens the window between initial pathogen exposure and official containment responses, reducing the need for blanket regional quarantines.

Commercializing State-Backed Biotechnology

The investment reflects a strategic pivot in South Africa’s public innovation strategy, transitioning state research funding toward commercial-stage technologies with direct economic protection utility.

As global standards for sanitary and phytosanitary (SPS) compliance tighten across export destinations, automated, real-time disease tracking is becoming a structural prerequisite for African agricultural producers competing in international markets. TIA's backing positions TokaBio to demonstrate the viability of locally developed biotech solutions in protecting national food security and export revenues.

The Intelligence Engine for African Private Capital

Access complete transaction breakdowns, fund strategy updates, and market commentary directly on our platform.